勃起功能障碍和心血管--代谢综合征:来自我们所有人的研究计划的见解
Cameron M Blazoski1, Zhiqi Yao1, Tobias S Kohler2
1Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Blalock 524D1, 600 North Wolfe Steet, Baltimore, MD 21287, USA.
American journal of preventive cardiology
|December 31, 2025
概括
勃起功能障碍 (ED) 与心血管--代谢 (CKM) 综合征有关. 这项研究发现ED与CKM疾病的患病率和发展有关,强调其在心脏代谢风险中的作用.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
- 内分泌学 在内分泌学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 勃起功能障碍 (ED) 是心血管疾病 (CVD) 的已知危险因素.
- 勃起障碍与心血管--代谢综合征 (CKM) 之间的关联需要进一步研究.
- 慢性瘤综合征包括一组相互关联的疾病,包括糖尿病,高血压,肥胖和慢性病.
研究的目的:
- 系统地调查ED与CKM疾病的流行之间的关联.
- 评估患有流行ED的个体未来发展CKM疾病的风险.
- 为了确定ED是否可以作为CKM综合征的早期指标.
主要方法:
- 利用了来自我们所有人的研究计划 (2017-2023) 的数据.
- 采用横截面分析来评估诊断ED和流行CKM条件之间的关联.
- 进行了生存分析,以检查ED与CKM疾病发生率之间的联系,在没有基线CKM问题的队列中.
主要成果:
- 在97,475名男性参与者中,5.7%的人初始有ED诊断.
- 与没有ED的参与者相比,ED的参与者显示T2DM,HTN,CKD,HF,ASCVD和AF的患病率明显更高.
- 流行性ED与患CKD,HF,AF,ASCVD和HTN的风险增加有关,但不是T2DM.
结论:
- ED与CKM条件的当前存在和未来发展显著相关.
- 建议将ED评估纳入常规心脏代谢风险评估中.
- 勃起障碍可能是潜在CKM综合征的关键早期预警信号.
更多相关视频
06:04Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
1.4K
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
12.1K
相关概念视频
01:29Hypertension II: Pathophysiology
700
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
700
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
437
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
437
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
874
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
874
01:30Coronary Artery Disease I: Introduction
846
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
846
01:24Chronic Kidney Disease II: Clinical Manifestations
520
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
520
01:25Chronic Kidney Disease I: Introduction
536
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
536